Revenues in USD of Intellipharmaceutics International Inc. from 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD and CAD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Intellipharmaceutics International Inc. quarterly/annual Revenues history and growth rate from 2010 to Q2 2023.
  • Intellipharmaceutics International Inc. Revenues for the quarter ending May 31, 2023 was $480K.
  • Intellipharmaceutics International Inc. Revenues for the twelve months ending May 31, 2023 was $789K.
  • Intellipharmaceutics International Inc. annual Revenues for 2022 was $65.7K.
  • Intellipharmaceutics International Inc. annual Revenues for 2021 was $0.000, a 100% decline from 2020.
  • Intellipharmaceutics International Inc. annual Revenues for 2020 was $1.4M, a 59.7% decline from 2019.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)

Intellipharmaceutics International Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $789K $480K +$480K Mar 1, 2023 May 31, 2023 6-K 2023-09-26
Q1 2023 $309K $326K +$243K +291% Dec 1, 2022 Feb 28, 2023 6-K 2023-09-26
Q4 2022 $65.7K -$36.8K +$56.7K +60.7% Sep 1, 2022 Nov 30, 2022 20-F/A 2024-02-06
Q3 2022 $9.05K $19.1K +$19.1K Jun 1, 2022 Aug 31, 2022 6-K 2022-10-14
Q2 2022 -$10K $0 -$93.4K -100% Mar 1, 2022 May 31, 2022 6-K 2023-09-26
Q1 2022 $83.4K $83.4K +$83.4K Dec 1, 2021 Feb 28, 2022 6-K 2023-09-26
Q4 2021 $0 -$93.4K -$393K -131% Sep 1, 2021 Nov 30, 2021 20-F/A 2024-02-06
Q3 2021 $393K $0 -$329K -100% Jun 1, 2021 Aug 31, 2021 6-K 2022-10-14
Q2 2021 $722K $93.4K -$302K -76.4% Mar 1, 2021 May 31, 2021 6-K 2022-07-21
Q1 2021 $1.02M $0 -$378K -100% Dec 1, 2020 Feb 28, 2021 6-K 2022-04-14
Q4 2020 $1.4M $299K +$66.9K +28.8% Sep 1, 2020 Nov 30, 2020 20-F/A 2024-02-06
Q3 2020 $1.33M $329K -$1.36M -80.5% Jun 1, 2020 Aug 31, 2020 6-K 2021-10-15
Q2 2020 $2.7M $396K -$819K -67.4% Mar 1, 2020 May 31, 2020 6-K 2021-07-15
Q1 2020 $3.51M $378K +$34K +9.9% Dec 1, 2019 Feb 29, 2020 6-K 2021-04-14
Q4 2019 $3.48M $233K -$155K -40% Sep 1, 2019 Nov 30, 2019 20-F/A 2022-05-09
Q3 2019 $3.64M $1.69M +$1.28M +309% Jun 1, 2019 Aug 31, 2019 6-K 2020-10-15
Q2 2019 $2.36M $1.21M +$638K +111% Mar 1, 2019 May 31, 2019 6-K 2020-07-15
Q1 2019 $1.72M $344K +$9.02K +2.7% Dec 1, 2018 Feb 28, 2019 6-K 2020-05-29
Q4 2018 $1.71M $388K Sep 1, 2018 Nov 30, 2018 20-F 2021-03-31
Q3 2018 $414K -$776K -65.2% Jun 1, 2018 Aug 31, 2018 6-K 2019-10-11
Q2 2018 $577K -$1.42M -71.2% Mar 1, 2018 May 31, 2018 6-K 2019-07-10
Q1 2018 $335K Dec 1, 2017 Feb 28, 2018 6-K 2019-04-15
Q3 2017 $1.19M Jun 1, 2017 Aug 31, 2017 6-K 2018-10-15
Q2 2017 $2M Mar 1, 2017 May 31, 2017 6-K 2018-07-24
Q1 2014 $4.68M Dec 1, 2013 Feb 28, 2014 6-K 2014-04-14

Intellipharmaceutics International Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $65.7K +$65.7K Dec 1, 2021 Nov 30, 2022 20-F/A 2024-02-06
2021 $0 -$1.4M -100% Dec 1, 2020 Nov 30, 2021 20-F/A 2024-02-06
2020 $1.4M -$2.08M -59.7% Dec 1, 2019 Nov 30, 2020 20-F/A 2024-02-06
2019 $3.48M +$1.77M +103% Dec 1, 2018 Nov 30, 2019 20-F/A 2022-05-09
2018 $1.71M -$3.79M -68.9% Dec 1, 2017 Nov 30, 2018 20-F 2021-03-31
2017 $5.5M Dec 1, 2016 Nov 30, 2017 20-F 2020-03-30
2015 $4.09M -$4.68M -53.3% Dec 1, 2014 Nov 30, 2015 20-F 2016-03-21
2014 $8.77M +$7.24M +474% Dec 1, 2013 Nov 30, 2014 20-F 2016-03-21
2013 $1.53M +$1.42M +1326% Dec 1, 2012 Nov 30, 2013 20-F 2016-03-21
2012 $107K -$395K -78.7% Dec 1, 2011 Nov 30, 2012 20-F 2015-02-27
2011 $502K -$958K -65.6% Dec 1, 2010 Nov 30, 2011 20-F 2014-02-18
2010 $1.46M Dec 1, 2009 Nov 30, 2010 20-F/A 2013-02-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.